Prostate Cancer With Intermediate Risk
1 clinical trials · Condition
◉ Watch Prostate Cancer With Intermediate Risk
| Record | Firm | Date |
|---|---|---|
| Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer (NCT01039038) | Centre Francois Baclesse | 2009-09-01 |
Track Prostate Cancer With Intermediate Risk automatically
Every clearance here is in the API, with alerts when new ones post.